Ben Auspitz - Profile and Investment Details

Investor Profile

Ben Auspitz is a Venture Capital, Private Equity Firm, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Orchard Therapeutics, Modis Therapeutics, Ultragenyx Pharmaceutical, IDRx, Ultragenyx Pharmaceutical Inc., CombinatoRx, Indalo Therapeutics, Dimension Therapeutics, Avidity Biosciences, Checkmate Pharmaceuticals, Compass Therapeutics, Inc., . Over time, Ben Auspitz has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ben Auspitz is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Pharmaceuticals may find it worthwhile to explore potential connections with Ben Auspitz, as their portfolio suggests a familiarity and interest in this area.

Understanding Ben Auspitz’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.